Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia

Abstract Acute myelogenous leukemia (AML) is a fatal blood cancer with high patient mortality. Daunorubicin and cytarabine are first‐line chemotherapy for AML, with bone marrow transplantation in most cases. Recently, cancer immunotherapy has been challenged in AML and leukemia‐niche myeloid cells a...

Full description

Bibliographic Details
Main Authors: Seok‐Beom Yong, Jaehyun Kim, Jee Young Chung, Sehee Ra, Seong Su kim, Yong‐Hee Kim
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202000487

Similar Items